A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)
      QxMD      Google Scholar   
Citation:
Oncologist vol 25 (6) 523-531
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
9
Parents:
738  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U10CA180866, U10CA180790, UG1CA189872  
Corr. Author:
 
Authors:
                 
Networks:
LAPS-MN026, UT056   
Study
NCCTG-N0623
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: